Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.53 |
| ▸ | DRD1 | P21728 | 1/20 | 0.53 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
| ▸ | CASR | P41180 | 1/20 | 0.53 |
| ▸ | HTR2B | P41595 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL479277 | 1.00 | CYP3A4 (0.53) | CYP3A4CHRM2HTR1AADRA2AADORA3 | |
| SCHEMBL8119644 | 1.00 | CYP3A4 (0.53) | CYP3A4CHRM2HTR1AADRA2AADORA3 | |
| Hydrochloric Acid SCHEMBL11627221 | 0.98 | CYP3A4 (0.55) | CYP3A4CHRM2HTR1AADRA2AADORA3 | |
| SCHEMBL2396763 | 0.81 | CYP3A4 (0.59) | CYP3A4CHRM2HTR1AADRA2AADORA3 | |
| SCHEMBL1784975 | 0.81 | CYP3A4 (0.59) | CYP3A4CHRM2HTR1AADRA2AADORA3 | |
| SCHEMBL1357332 | 0.81 | CYP3A4 (0.59) | CYP3A4CHRM2HTR1AADRA2AADORA3 | |
| SCHEMBL10839595 | 0.81 | GAA (0.44) | CYP3A4CHRM2HTR1AADRA2AADORA3 | |
| SCHEMBL10582023 | 0.79 | SMN1; SMN2 (0.46) | CYP3A4LMNACYP2C19SMN1; SMN2KMT2A | |
| SCHEMBL6724867 | 0.79 | MTOR (0.58) | CYP3A4LMNACYP2C19SMN1; SMN2MEN1 | |
| SCHEMBL31620151 | 0.78 | CYP2D6 (0.55) | CYP3A4CHRM2ADRA2ASLC6A4ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111193069-B | Electrolyte for electrochemical device, method for preparing the same, and electrochemical device | 三星电子株式会社 | 2024-11-01 | — | — | CN | claimed |
| US-6060617-A | REACTING AN ALKALI METAL HYDRIDE AND ALKALI METAL AMIDES WITH A SUBSTITUTED AMINE IN AN ETHER SOLVENT IN ABSENCE OF AN ELECTRON CARRIER TO PRODUCE AN ALKALI METAL AMIDE FREE OF ORGANIC CONTAMINANTS | FMC CORPORATION (US) | 2000-05-09 | — | — | US | claimed |
| EP-0736031-B1 | IMPROVEMENTS IN OR RELATING TO CHIRAL SYNTHESES | OXFORD ASYMMETRY INTERNATIONAL (GB) | 2000-05-03 | — | — | EP | claimed |
| US-6037498-A | Chiral syntheses | OXFORD ASYMMETRY INTERNATIONAL PLC (GB) | 2000-03-14 | — | — | US | claimed |
| US-5726308-A | High purity formulations of highly substituted lithium amide bases | FMC CORPORATION (US) | 1998-03-10 | — | — | US | claimed |
| JP-H09507221-A | — | — | 1997-07-22 | — | — | JP | claimed |
| WO-1995018134-A1 | IMPROVEMENTS IN OR RELATING TO CHIRAL SYNTHESES | OXFORD ASYMMETRY LIMITED (GB) | 1995-07-06 | — | — | WO | claimed |
| CN-111193069-B | Electrolyte for electrochemical device, method for preparing the same, and electrochemical device | 三星电子株式会社 | 2024-11-01 | — | — | CN | disclosed |
| EP-3498717-B1 | COMPOSITION FOR HARDENING SOFT TISSUE | CATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION (KR) | 2022-05-04 | — | — | EP | disclosed |
| EP-1979348-B1 | ANTI-VIRAL COMPOUNDS | ABBOTT LAB (US) | 2012-01-18 | — | — | EP | disclosed |
| US-7910595-B2 | Anti-viral compounds | ABBOTT LABORATORIES (US) | 2011-03-22 | — | — | US | disclosed |
| US-20070232627-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. | 2007-10-04 | — | — | US | disclosed |
| US-6060617-A | REACTING AN ALKALI METAL HYDRIDE AND ALKALI METAL AMIDES WITH A SUBSTITUTED AMINE IN AN ETHER SOLVENT IN ABSENCE OF AN ELECTRON CARRIER TO PRODUCE AN ALKALI METAL AMIDE FREE OF ORGANIC CONTAMINANTS | FMC CORPORATION (US) | 2000-05-09 | — | — | US | disclosed |
| EP-0736031-B1 | IMPROVEMENTS IN OR RELATING TO CHIRAL SYNTHESES | OXFORD ASYMMETRY INTERNATIONAL (GB) | 2000-05-03 | — | — | EP | disclosed |
| US-6037498-A | Chiral syntheses | OXFORD ASYMMETRY INTERNATIONAL PLC (GB) | 2000-03-14 | — | — | US | disclosed |
| US-5726308-A | High purity formulations of highly substituted lithium amide bases | FMC CORPORATION (US) | 1998-03-10 | — | — | US | disclosed |
| WO-1997002210-A2 | CONTAMINANT FREE ORGANOMETALLIC AMIDE COMPOSITIONS AND PROCESSES FOR MAKING SAME | FMC CORPORATION (US) | 1997-01-23 | — | — | WO | disclosed |
| EP-0736031-A1 | IMPROVEMENTS IN OR RELATING TO CHIRAL SYNTHESES | OXFORD ASYMMETRY LIMITED (GB) | 1996-10-09 | — | — | EP | disclosed |
| WO-1995018134-A1 | IMPROVEMENTS IN OR RELATING TO CHIRAL SYNTHESES | OXFORD ASYMMETRY LIMITED (GB) | 1995-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232627-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, MAVS, EIF2AK2 | CYP3A4 273/4885CHRM2 4885/4885HTR1A 4760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.